These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12960153)

  • 1. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines.
    Bretscher LE; Li H; Poulos TL; Griffith OW
    J Biol Chem; 2003 Nov; 278(47):46789-97. PubMed ID: 12960153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
    Babu BR; Griffith OW
    J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
    J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
    Bryk R; Lubeskie A; Wolff DJ
    Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
    Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
    Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptides containing L-arginine analogs: new isozyme-selective inhibitors of nitric oxide synthase.
    Kobayashi N; Higuchi T; Urano Y; Kikuchi K; Hirobe M; Nagano T
    Biol Pharm Bull; 1999 Sep; 22(9):936-40. PubMed ID: 10513616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the selectivity of neuronal NOS inhibitors.
    Pigott B; Bartus K; Garthwaite J
    Br J Pharmacol; 2013 Mar; 168(5):1255-65. PubMed ID: 23072468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal nitric oxide synthase inhibition improves diastolic function and reduces oxidative stress in ovariectomized mRen2.Lewis rats.
    Jessup JA; Zhang L; Chen AF; Presley TD; Kim-Shapiro DB; Chappell MC; Wang H; Groban L
    Menopause; 2011 Jun; 18(6):698-708. PubMed ID: 21293310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-2-amino-5-azolylpentanoic acids related to L-ornithine as inhibitors of the isoforms of nitric oxide synthase (NOS).
    Ulhaq S; Chinje EC; Naylor MA; Jaffar M; Stratford IJ; Threadgill MD
    Bioorg Med Chem; 1998 Nov; 6(11):2139-49. PubMed ID: 9881104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
    Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
    Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
    Handy RL; Moore PK
    Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of N-hydroxylation as a prerequisite mechanism of nitric oxide synthase inactivation.
    Maurer TS; Pan J; Booth BP; Kalman TI; Fung HL
    Bioorg Med Chem Lett; 2000 May; 10(10):1077-80. PubMed ID: 10843221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional NOS 1 in the rat mesenteric arterial bed.
    Sullivan JC; Giulumian AD; Pollock DM; Fuchs LC; Pollock JS
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H658-63. PubMed ID: 12124213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of isoform-selective inhibitors of nitric oxide synthase.
    Babu BR; Griffith OW
    Curr Opin Chem Biol; 1998 Aug; 2(4):491-500. PubMed ID: 9736922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for isoform-selective inhibition in nitric oxide synthase.
    Poulos TL; Li H
    Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.
    Matter H; Kumar HS; Fedorov R; Frey A; Kotsonis P; Hartmann E; Fröhlich LG; Reif A; Pfleiderer W; Scheurer P; Ghosh DK; Schlichting I; Schmidt HH
    J Med Chem; 2005 Jul; 48(15):4783-92. PubMed ID: 16033258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
    Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
    Boumezber S; Yelekçi K
    J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.